Form 4 Tracker
Ryan Cohlhepp

Director, President and COO · 8 filings · Latest: May 15, 2026

Bicara Therapeutics Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
BCAX
Cohlhepp RyanNov 21, 2025
Proposed Sale
$18.0512,500$225.6K
BCAX
Cohlhepp RyanOct 15, 2025
Proposed Sale
$18.1312,500$226.6K
BCAX
Cohlhepp RyanOct 7, 2025
Proposed Sale
$18.0010,900$196.2K
BCAX
Cohlhepp RyanOct 6, 2025
Proposed Sale
$18.0639,600$715.0K

← Previous

Page 2 of 2